Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03381911 · ClinicalTrials.gov registry record · NA

ECA vs E-Document Explanation

A NA study, sponsored by Boston Medical Center.

Completed
Registry status
NA
Development phase
35
Enrollment target

NCT03381911 is a NA study that has completed, run by Boston Medical Center. The registered enrollment target is 35 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03381911, a NA study, has completed, sponsored by Boston Medical Center.

COMPLETED
Registry status
NA
Development phase
35 participants
Enrollment target

Study Summary

This study will investigate how consent forms and other health care documents are explained to patients. The findings will be used to create a computer program that can successfully explain consent and other health-related forms to individuals who have difficulty reading and understanding consent forms on their own as a supplement to the normal consent process done in research settings. In a prior study, the investigators delivered a similar protocol, where subjects were first consented and then given a mock consent form (administered in 1 of 3 arms: RA, ECA, or ECA + RA). Subjects in this protocol struggled with the concept of a "mock" consent process, especially after they had just completed a consent process for the study itself. The current protocol, using deception research methods, aims to provide a more pure assessment of ECA consent vs the standard (here, E-consent) by waiving consent and delivering the sham consent as if it were reality. In the context of a protocol that employs deception methods, participants in the current study would be invited as healthy volunteers, and be randomized to 1 of 2 different consent processes to evaluate the relative benefits of different approaches for informed consent. After the knowledge tests have been completed, subjects will undergo a debriefing where they are made fully aware of the deception and its purpose. At that time, subjects will also be given the opportunity to "opt out" and not have their data included in the study results.

Interventions

  • OTHER Embodied Conversational Agent

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2018-01-04
Est. Completion 2018-04-18
Phase NA

Sponsor

Boston Medical Center

253 total trials

What the Registry Record Tells You About NCT03381911

The ClinicalTrials.gov registry entry for NCT03381911 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Embodied Conversational Agent is the first listed.

NCT03381911 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03381911 about?

NCT03381911 is a clinical study titled "ECA vs E-Document Explanation". This study will investigate how consent forms and other health care documents are explained to patients. The findings will be used to create a computer program that can successfully explain consent and other health-related forms to individuals who have difficulty reading and understanding consent fo...

What is the current status of trial NCT03381911?

This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2018-01-04. Estimated completion is 2018-04-18.

What interventions are being tested in trial NCT03381911?

The interventions under investigation include: Embodied Conversational Agent (OTHER).

Who is sponsoring clinical trial NCT03381911?

This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.